ACCO Brands (ACCO) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
Annual Meeting scheduled for May 20, 2025, to be held virtually, with voting on key proposals including director elections, auditor ratification, executive compensation, and an amendment to the incentive plan.
2024 achievements include $25 million in cost savings, expansion of the cost reduction program to $100 million, gross margin improvement, and $94 million net debt reduction.
Net sales for 2024 were $1.67 billion, with a net loss of $101.6 million, primarily due to non-cash impairment charges; adjusted operating income was $189.7 million.
Capital allocation priorities include continued debt reduction, share repurchases, and support for quarterly dividends.
Voting matters and shareholder proposals
Proposals include election of nine directors, ratification of KPMG LLP as auditor, advisory vote on executive compensation, and approval of an amendment to the incentive plan to increase available shares.
Board recommends voting FOR all proposals.
No other business is currently anticipated at the meeting.
Board of directors and corporate governance
Board consists of nine members, 89% independent, with an average tenure of 7.8 years; three women and two ethnically diverse directors.
All directors attended over 85% of meetings in 2024.
Board leadership structure separates Chairman and CEO roles; E. Mark Rajkowski serves as independent Chairman.
Annual board and committee self-evaluations are conducted.
Stock ownership guidelines require directors to hold five times their annual cash retainer in company stock.
Latest events from ACCO Brands
- 2026 proxy covers director elections, auditor ratification, executive pay, and incentive plan amendment.ACCO
Proxy filing27 Mar 2026 - Virtual annual meeting to vote on directors, auditor, executive pay, and incentive plan amendment.ACCO
Proxy filing27 Mar 2026 - 2025 results met outlook with $1.525B sales, $0.84 EPS, and a strategic tech pivot.ACCO
Q4 20259 Mar 2026 - Adjusted EPS beat outlook as cost actions offset sales decline and impairment charges.ACCO
Q2 20242 Feb 2026 - Q3 sales fell 6%, but cost savings, cash flow, and margins improved despite impairment charges.ACCO
Q3 202417 Jan 2026 - 2024 saw lower sales but higher margins and cash flow; 2025 outlook remains stable.ACCO
Q4 202423 Dec 2025 - Shareholders will vote virtually in May 2025 on directors, auditor, pay, and plan amendment.ACCO
Proxy Filing1 Dec 2025 - Shareholders to vote virtually on directors, auditor, compensation, and incentive plan amendment.ACCO
Proxy Filing1 Dec 2025 - Sales fell 11.6%, but gross margin and adjusted EPS beat expectations amid market headwinds.ACCO
Q1 202528 Nov 2025